Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Rapid test results are needed to interrupt the chain of coronavirus transmission.
Mobile clinics could be innovative strategy for expanding access to care and providing uninterrupted treatment for people who inject drugs.
The trial will inform public health policy on the potential use of mixed vaccine schedules if booster doses are needed.
Research suggests how to develop more broadly effective therapies and vaccines.
Researchers used an airway-on-a-chip that mimics living lung tissue to screen approved drugs for use against SARS-CoV-2.
Cancer, diabetes and Alzheimer’s would be the initial focus for the proposed agency within the National Institutes of Health.
People with long COVID have diverse clinical conditions that will require individualized and multidisciplinary approaches to treatment.
Questions remain about whether people with HIV are more at risk for severe COVID-19, as evidence to date is mixed.
Research suggests protective effect of natural infection or vaccination is likely to be persistent.
Study findings may help explain why wearing masks has been linked to lower disease severity in people with COVID-19.
People who have had COVID-19 appear to be protected against reinfection for at least a few months.
Large numbers of people continue to experience symptoms long past the time that they’ve recovered from initial COVID-19 illness.
NIAID director Anthony Fauci, MD, and coauthors emphasize the need for a global response to COVID-19.
But new data add to the evidence that mother-to-infant transmission of the coronavirus appears to be rare.
More than 95% of people who recovered from COVID-19 had durable immune system memory up to eight months after infection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.